secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2026-07-28T20:03:12+00:00
Accession:  0001437749-26-024663
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health Q2 TRCV up 11% to $151.9M; adj. EPS $0.31 vs. GAAP loss ($0.15)
--------------------------------------------------------------------------

- Total revenue $35.4M, up 4% YoY; GAAP net loss ($3.3M) vs. adjusted net income $6.9M.
- Adjusted EBITDA $9.4M (27% of revenue); free cash flow $0.1M after $2.9M cash payment for accelerated vesting.
- TRCV $151.9M, up 11% YoY; strongest bookings for The Governance Institute in seven years.
- GAAP diluted EPS ($0.15); adjusted diluted EPS $0.31 on 22.0M shares.
- CEO cites double-digit TRCV growth, strong go-to-market execution, and product innovation commercialization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774926024663/0001437749-26-024663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774926024663/nrc20260724_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-024663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer